Hans Hull, Chief Business Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 9,900 shares at $11.56 ($114K) on 2024-07-10, disclosed to the SEC on 2024-07-12.
Scheduled sale ($114k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PLRX | SELL | 2023-08-07 | $1.1M | — | Filing → |
| PLRX | SELL | 2023-07-19 | $646K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $479K | — | Filing → |